Latest Therapeutic hypothermia Stories
A distinctive pattern of brain activity associated with conditions including deep anesthesia, coma and congenital brain disorders appears to represent the brain's shift into a protective, low-activity state in response to reduced metabolic energy.
Physicians may be making premature predictions about which patients are not likely to survive following cardiac arrest – and even withdrawing care -- before the window in which comatose patients who have received therapeutic hypothermia are most likely to wake up.
Cardiomyopathy is common among cardiac arrest survivors.
Delay in initiation of therapeutic hypothermia and delay in return of spontaneous circulation (ROSC), evidenced by a palpable pulse or a measurable blood pressure, were both associated with poor neurologic outcomes in post cardiac arrest patients.
Discussion about cardiac arrest on Twitter is common and represents a new opportunity to provide lifesaving information to the public.
More than 200,000 people are treated for cardiac arrest in United States hospitals each year, a rate that may be on the rise.
BROADVIEW HEIGHTS, Ohio, June 16, 2011 /PRNewswire-USNewswire/ -- Life Core Technologies, a medical device company that has developed a series of products that improve outcomes by preventing brain damage through a novel approach to therapeutic hypothermia, today announced Michael Burke as president and chief executive officer.
A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective.